Litteraturliste

Litteraturlisten omfatter ikke hele underlagsmaterialet for innstillingen, men er et utvalg av viktige dokumenter relatert til xenotransplantasjon.

Albrechtsen D. Lønner det seg å transplantere organer? Tidsskrift for Den norske lægeforening 1999; 119: 3886.

Bach FH, Fishman JA, Daniels N, Proimos J, Anderson B, Carpenter CB, Forrow L, Robson SC, Fineberg HV. Uncertainty in xenotransplantation: Individual benefit versus collective risk. Nature Medicine 1998; 4:141-144.

Beauchamp T, Childress JF. Principles of Biomedical Ethics. 3. ed. Oxford University Press, New York 1989.

Bioteknologinemnda. Xenotransplantasjon - transplantasjon fra dyr til menneske: Vil vi ha det? Rapport fra Bioteknologinemndas åpne høring 30. september, 1998.

Boneva RS, Folks TM, Chapman LE. Infectious disease issues in xenotransplantation. Clinical Microbiology Reviews 2001; 14:1-14.

Bruce, D and Bruce A (red.). Engineering Genesis. The Ethics of Genetic Engineering. Earthscan, London 1998.Cooper DK, Keogh AM, Brink J, Corris PA, Klepetko W, Pierson RN, Schmoeckel M, Shirakura R, Warner Stevenson L. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. The Journal of Heart and Lung Transplantation 2000; 19:1125-1165.

Cooper, DKC, Lanza, R. Xeno. The promise of transplanting animal organs into humans. Oxford University Press, Oxford 2000.

Cooper, DKC. et al. (eds.), Xenotransplantation. The Transplantation of Organs and Tissues Between Species 2. ed.. Springer-Verlag, Berlin 1997.

Council of Europe Working Party on Xenotransplantation (Steering Committee on Bioethics (CDBI) and the European Health Committee (CDSP) -XENO), Interim state-of-the-art report in the field of xenotransplantation.Strasbourg, 3. mai 2000.

Christoffersen SA. Xenotransplantasjon. Tidsskrift for Den norske lægeforening 1999; 119: 4160.

Ekeberg Ø, Loge JH. Pasientens livskvalitet etter transplantasjon - hva vet vi? Tidsskrift for Den norske lægeforening, 1999;119: 3920-3923.

Fiane, A og Mollnes TE. Transplantasjon fra dyr til menneske. Tidsskrift for Den norske lægeforening 1999; 119: 4213-4218.

Fiane, A, Geiran O, Søreide O, Thorsby E, Aasen AO. Organtransplantasjon med dyreorganer (xenotransplantasjon). Status og fremtidig utvikling. Tidsskrift for Den norske lægeforening 1997; 117: 1071-1076.

Føllesdal, A (red.). Dyreetikk. Fagbokforlaget, Oslo 2000.Hammer C. Physiological obstacles after xenotransplantation. Annals New York Academy of Sciences 1998; 862: 19-27.

Le Tissier P, Stoye JP, Takeuchi Y, Patience C, Weiss RA. Two sets of human-tropic pig retrovirus. Nature.1997; 389: 681-682.

Lundin S, Widner H.Patientröster om xenotransplantation: «Jag skulla göra allt, för jag vill inte dö!» Läkartidningen 2000, 97: 1940-1943.

Lien B, Brekke BB. Hvordan sikre best mulig tilgang på organer for transplantasjon? Tidsskrift for Den norske lægeforening 1999; 119: 3610-3614.

Michaels MG, Jenkins FJ, St George K, Nalesnik MA, Starzl TE, Rinaldo CR Jr. Detection of infectious baboon cytomegalovirus after baboon-to-human liver xenotransplantation. Journal of Virology 2001;75: 2825-2858.

National Heart Lung and Blood Institute. Expert Panel Review of the NHLBI Total Artifical Heart Program, June 1998- November 1999. (http://www.nhlbi.nih.gov/resources/docs/tah-rpt.htm)

National Institutes of Health, Stem Cells: A Primer. May 2000. (http://www. nih.gov/news/stemcell/primer.htm)

Nuffield Council on Bioethics, Animal-to-Human Transplants. The Ethics of Xenotransplantation. London, 1996. (http://www.nuffield.org/bioethics/publication/transplants/rep0000000030.html)

OECD. Xenotransplantation: International Policy Issues. OECD Proceedings, Paris 1999.

Onishi A, Iwamoto M, Akita T, Mikawa S, Tekada K, Awata T, Hanasa H, Perry A, Pig Cloning by Microinjection of Fetal Fibroblast Nuclei. Science 2000; 289: 1188-1190.

Platt, JL, Xenotransplantation. New risks, new gains. Nature 2000; 407: 27-30.

Polejaeva IA, Chen SH, Vaught TD, Page RL, Mullins J, Ball S, Dai Y, Boone J, Walker S, Ayares DL, Colman A, Campbell KH. Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 2000; 407: 505-509.

Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, Chapman LE, Lockey C, Onions D, Otto E. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999; 285: 1236-1241.

Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nature Medicine 1997; 3: 282-286.

Patience C, Switzer WM, Takeuchi Y, Griffiths DJ, Goward ME, Heneine W, Stoye JP, Weiss RA. Multiple groups of novel retroviral genomes in pigs and related species. Journal of Virology 2001; 75: 2771-2775.

Ruyter K, FørdeR, Solbakk JH. Medisinsk etikk - en problembasert tilnærming. Gyldendal, Oslo 2000.

Statens Offentliga Utredningar 1999:120, Från en art till en annan - transplantation från dyr til människa. Betänkande av Xenotransplantationskomiteen, Socialdepartementet, Stockholm.

Stoye JP, Le Tissier P, Takeuchi Y, Patience C, Weiss RA. Endogenous retroviruses: a potential problem for xenotransplantation? Annals New York Academy of Sciences 1998; 862: 67-74.

Sosial- og helsedepartementet. Stamceller fra aborterte fostre og befruktede egg - medisinsk forskning, klinisk anvendelse og mulige alternativer. Rapport fra arbeidsgruppe, mai 2000. (http://www.dep.no/shd/norsk/dep/utvalg/030071-080002/index-dok000-b-n-a.html)

The advisory group on the ethics of xenotransplantation. Animal tissue into humans. UK Stationary Office 1996.

Tranøy, KE. Medisinsk etikk i vår tid. Fagbokforlaget, Bergen 1999.

United Kingdom Xenotransplantation Interim Regulatory Authority (UKXIRA). Draft guidance notes on biosecurity considerations in relation to xenotransplantation, UKXIRA, 4. Okt.1999. (http://www.doh.gov.uk/biosecurity.htm)

United Kingdom Xenotransplantation Interim Regulatory Authority (UKXIRA). Draft report of the infection surveillance steering group of the UKXIRA, 4. Aug.1999.

(http://www.doh.gov.uk/surveil.htm)

U.S. Food and Drug Administration. Availibility for public disclosure and submission to FDA for public disclosure of certain data and information related to human gene therapy or xenotransplantation; Proposed Rule. 18.01.2001. (http://www.fda.gov/cber/rules/frgene011801.pdf)

U.S. Public Health Service. PHS Guideline on infectious disease issues in xenotransplantation. 19.01.2001. (http://www.fda.gov/cber/gdlns/xenophs0101.htm)

U.S. Public Health Service. Draft guidance for industry: source animal, product, preclinical and clinical issues concerning the use of xenotransplantation products in humans. 07.02.2001. (http://www.fda.gov/cber/gdlns/clinxeno0201.pdf)

van der Laan LJ, Lockey C, Griffeth BC, Frasier FS, Wilson CA, Onions DE, Hering BJ, Long Z, Otto E, Torbett BE, Salomon DR. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 2000; 407: 90-94.

Verdens legeforening. Helsinkideklarasjonen. Etiske prinsipper for medisinsk forskning som omfatter mennesker. Oktober 2000. (http://www.etikkom.no/NEM/REK/deklarasjon00.htm)

Welin S. Starting clinical trials of xenotransplantation - reflections on the ethics of the early phase. Journal of Medical Ethics 2000; 26:231-236.

Welin S. The future of Xenotransplantation - What are the ethical problems? Transplantation Proceedings 2000; 32:1177-1178.

Westaby S, Banning AP, Jarvik R, Frazier OH, Pigott DW, Jin XY, Catarino PA, Saito S, Robson D, Freeland A, Myers TJ, Poole-Wilson PA. First permanent implant of the Jarvik 2000 Heart.Lancet 2000; 356: 900-903.